GMED is pleased to announce that Shahriar Sharifi and Florianne Torset-Bonfillou will be representing our organization at the forthcoming Global Regulatory Strategy Conference, to be held in Baltimore on March 5-6, 2026. This distinguished event will feature presentations by our colleagues on significant topics in the regulatory landscape.
Shahriar will deliver a presentation entitled “From Nonconformities to Insight: Leveraging Biocompatibility Assessment Trends for Regulatory Intelligence and Strategic Compliance,” which will provide an in-depth examination of current trends in biocompatibility assessment and their implications for compliance and regulatory strategy. Florianne will present on “How can a strong Quality system support a manufacturer’s regulatory strategy?” highlighting the essential role of comprehensive quality systems in the effective implementation of regulatory frameworks.
We encourage attendees to participate in these sessions and engage with Shahriar and Florianne to explore advanced strategies and best practices in regulatory intelligence and quality management. GMED looks forward to meaningful exchanges with industry professionals at this notable conference in Baltimore.